title: Interval cancers in the Dutch breast cancer screening programme.
abstract: The nationwide breast cancer screening programme in The Netherlands for women aged 50-69 started in 1989. In our study we assessed the occurrence and stage distribution of interval cancers in women screened during 1990-1993. Records of 0.84 million screened women were linked to the regional cancer registries yielding a follow-up of at least 2.5 years. Age-adjusted incidence rates and relative (proportionate) incidences per tumour size including ductal carcinoma in-situ were calculated for screen-detected and interval cancers, and cancers in not (yet) screened women, comparing them with published data from the UK regions North West and East Anglia. In total 1527 interval cancers were identified: 0.95 and 0.99 per 1000 woman-years of follow-up in the 2-year interval after initial and subsequent screens respectively. In the first year after initial screening interval cancers amounted to 27% (26% after subsequent screens) of underlying incidence, and in the second year to 52% (55%). Generally, interval cancers had a more favourable tumour size distribution than breast cancer in not (yet) screened women. The Dutch programme detected relatively less (favourable) invasive cancers in initial screens than the UK programme, whereas the number of interval cancers confirms UK findings. Measures should be considered to improve the detection of small invasive cancers and to reduce false-negative rates, even if this will lead to increasing referral rates.
authors.affiliation: Department of Public Health, Erasmus University Rotterdam, The Netherlands.
authors.forename: J
authors.initials: J
authors.lastname: Fracheboud
authors.forename: H J
authors.initials: HJ
authors.lastname: de Koning
authors.forename: P M
authors.initials: PM
authors.lastname: Beemsterboer
authors.forename: R
authors.initials: R
authors.lastname: Boer
authors.forename: A L
authors.initials: AL
authors.lastname: Verbeek
authors.forename: J H
authors.initials: JH
authors.lastname: Hendriks
authors.forename: B M
authors.initials: BM
authors.lastname: van Ineveld
authors.forename: M J
authors.initials: MJ
authors.lastname: Broeders
authors.forename: A E
authors.initials: AE
authors.lastname: de Bruyn
authors.forename: P J
authors.initials: PJ
authors.lastname: van der Maas
mesh_terms: D000368:Aged; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000453:epidemiology* / Q000473:pathology / Q000517:prevention & control; D002278:Carcinoma in Situ / Q000175:diagnosis / Q000453:epidemiology / Q000473:pathology / Q000517:prevention & control; D018270:Carcinoma, Ductal, Breast / Q000175:diagnosis / Q000453:epidemiology* / Q000473:pathology / Q000517:prevention & control; D005260:Female; D006801:Humans; D015994:Incidence; D008403:Mass Screening; D008875:Middle Aged; D009367:Neoplasm Staging; D009426:Netherlands / Q000453:epidemiology; D012042:Registries; D013997:Time Factors; D006113:United Kingdom / Q000453:epidemiology